Lexicon Pharmaceuticals to Participate in the 13th Annual Jefferies London Healthcare Conference
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the 13th Annual Jefferies London Healthcare Conference, taking place November 15-17, 2022
By Lexicon Pharmaceuticals, Inc.
Published - Nov 11, 2022, 09:13 AM ET
Last Updated - Mar 25, 2024, 04:39 PM EDT
THE WOODLANDS, Texas, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the 13th Annual Jefferies London Healthcare Conference, taking place November 15-17, 2022.
Jeff Wade, Lexicon’s president and chief financial officer, will make a company presentation for the Jefferies conference which will be available on-demand beginning at 7:55 am ET/12:55 pm GMT on Wednesday, November 16, 2022.
The webcast will be available in the “Events” section of the Lexicon website at www.lexpharma.com/events, and a recording of the webcast will be available for two weeks following the original on-demand date.
About Lexicon Pharmaceuticals
